1-3 of 3
Andrew Stein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sabatolimab (MBG453) Dose Selection and Dose-Response Analysis in Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML): Population Pharmacokinetics (PK) Modeling and Evaluation of Clinical Efficacy/Safety By Dose

Andrew H. Wei, MBBS, PhD, Jordi Esteve, Kimmo Porkka, Steve Knapper, Norbert Vey, MD, Sebastian Scholl, Guillermo Garcia-Manero, MD, Martin Wermke, Jeroen Janssen, Elie Traer, Sun Loo, Rupa Narayan, Natalia Tovar, Mika Kontro, Oliver Ottmann, Siyan Xu, Serena Liao, Andrew Stein, Fariba Khanshan, Purushotham Naidu, Na Zhang, Anisa Mohammed, Mikael L. Rinne, Haiying Sun, Andrew M. Brunner, MD, Uma Borate
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–42.
https://doi.org/10.1182/blood-2020-137307
Published: 2020
Journal Articles

Evaluation of MMR Concordance Based on Either International Scale (IS) or National Comprehensive Cancer Network (NCCN) Criteria Using Reconstructed “Virtual” CML Patient Profiles From the REVEAL BCR-ABL Methods Comparison Study,

Poluru L. Reddy, PhD, DABCC, Paul Choppa, Mike M. Moradian, PhD, Nicholas T. Potter, PhD, FACMG, Michael M. Quigley, MD, Christopher D. Watt, MD, PhD, Holger Höfling, PhD, Brian Manning, PharmD, Andre Mignault, MS, Brian Mullaney, MD, PhD, Diego Ossa, MD, MSc, Andrew Stein, PhD, Sha-Sha Wang, PhD, Feng Yang, PhD, Meir Wetzler, MD
Journal: Blood
Blood (2011) 118 (21): 3542.
https://doi.org/10.1182/blood.V118.21.3542.3542
Published: 2011
Journal Articles

Bcr-Abl Kinetics Suggest Self-Renewing Leukemic Cells Are Reduced During Imatinib Treatment.

Andrew Stein, PhD, Thea Kalebic, MD, Dean Bottino, PhD
Journal: Blood
Blood (2009) 114 (22): 506.
https://doi.org/10.1182/blood.V114.22.506.506
Published: 2009